Cystic degeneration/spongiosis hepatis in rats has been proposed to be a preneoplastic and/or neoplastic lesion by some authors, because of its proliferative properties and persistent increased cell turnover rate in stop experiments using hepatocarcinogens , and the assumption that it can develop into a sarcoma. The neoplastic potential of cystic degeneration is questioned in this review article. Cystic degeneration, which appears to derive from altered Ito cells, does not have neoplastic histomorphologi c characteristics, although it may be composed of cells with an increased mitotic index. In this regard, persistent proliferation is also seen with other nonneoplastic lesions. Arguments are presented to show that the induced, probably extremely rare sarcoma that was associated with cystic degeneration most likely derives from the very rare induced spherical Ito-cell aggregate with an unusually high cellular turnover rate in rats treated with hepatocarcinogens , and not from cystic degeneration. Also, in none of 12 referenced standard oncogenicity studies with chemically induced cystic degeneration was the lesion associated with mesenchymal (Ito-cell) tumors. Consequently, evidence is lacking that cystic degeneration in rats should be classifi ed as a preneoplastic or neoplastic lesion.
The 12 oncogenicity studies in rats with induced cystic degeneration showed a marked sex predilection, with males more likely to develop either spontaneous or chemically induced lesions. In these 12 studies, cystic degeneration was more often associated with hepatocellular hypertrophy or hepatotoxicity, rather than hepatocarcinogenicity. Thus, it is concluded that hepatocarcinogens induce cystic degeneration, not because they are carcinogenic, but because they have other effects on the liver, and that cystic degeneration may be a secondary/reparative change. Cystic degeneration in fi sh parallels the situation in rats in many respects, yet the existence of the lesion in other species, including man, is not as well supported. Based on the data presented in this review, spontaneous and induced cystic degeneration in rats and fi sh is not a preneoplastic or neoplastic lesion and risk assessment for man can be based on no-effect levels and safety margins, as for other nonneoplasti c adverse effects that have no counterpart in man.
Amenta PS, Martinez-Hernándes A., Trelstad RL (1990). Repair and Regeneration. In: Anderson's Pathology, 10th ed, Domjanov ID, Linder J (eds). Mosby, St. Louis, pp 438—439.
2.
Ankoma-Sey V. , Matli M., Chang KB, Lalazar A., Donner DB, Wong L., Warren RS, Friedman SL (1998). Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing . Oncogene17(1): 115—121.
3.
Ballardini G. , Groff P., Badiali de Giorgi L., Schuppan D., Bianchi FB (1994). Ito cell heterogeneity: Desmin-negative Ito cells in normal rat liver . Hepatology19(2): 440—446.
4.
Bannasch P. (1983). Strain and species differences in susceptibility to liver tumour induction. In: Modulators of Experimental Carcinogenesis , Turusov V, Montesano R (eds). IARC Scientifi c Publications No. 51, Lyon, pp 9—38.
5.
Bannasch P., Block M., Zerban H. (1981). Spongiosis hepatis. Specifi cchanges of the perisinusoidal liver cells induced in rats by N-nitrosomorpholine. Lab Invest44: 252—264.
6.
Bannasch P., Zerban H. (1986). Pathogenesi s of primary liver tumors induced by chemicals. Recent Results Cancer Res100: 1—15.
7.
Bannasch P., Zerban H. (1994). Preneoplastic and neoplastic lesions of the rat liver. In: Pathology of Neoplasia and Preneoplasia in Rodents, EULEP Color Atlas. Bannasch P, Gö ssner W (eds). Schattauer, Stuttgart, pp. 18— 63.
8.
Bannasch P., Zerban H. (1997). Spongiosis hepatis and spongiotic pericytoma, rat. In: Monographs on Pathology of Laboratory Animals, Digestive System, Jones TC, Popp JA, Mohr U (eds). Springer, Berlin, pp 104—113.
9.
Bannasch P., Zerban H., Fü gel HJ (1985). Spongiosis hepatis, rat. In: Monographs on Pathology of Laboratory Animals, Digestive System. Jones TC, Mohr U, Hunt RD (eds). Springer, pp 116—123.
10.
Benyon RC, Hovell CJ, Da Gaca M., Jones EH, Iredale JP, Arthur MJ (1999). Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology30(4): 977— 986.
11.
Boorman GA, Botts S., Bunton TE, Fournie JW, Harshbarger JC, Hawkins WE, Hinton DE, Jokinen MP, Okihiro MS, Wolfe MJ (1997). Diagnostic criteria for degenerative, infl ammatory, proliferative non-neoplastic and neoplastic liver lesions in medaka (Oryzias latipes): Consensus of a National Toxicology Program pathology working group . Toxicol Pathol25: 202—210.
12.
Buniatian G. , Gebhardt R., Schrenk D., Hamprecht B. (1996). Colocalization of three types of intermediate fi lament proteins in perisinusoidal stellate cells: Glial fi brillary acidic protein as a new cellular marker . Eur J Cell Biol70(1): 23—32.
13.
Bunton TE (1990). Hepatopathology of diethylnitrosamine in the medaka (Oryzias latipes) following short-term exposure. Toxicol Pathol18: 313— 323.
14.
Bunton TE (1995). Expression of actin and desmin in experimentally induced hepatic lesions and neoplasms from medaka (Oryzias latipes). Carcinogenesis16: 1059—1063.
15.
Burek JD (1978). Pathology of Aging Rats. CRC Press, West Palm Beach, Florida.
16.
Couch JA (1991). Spongiosis hepatis: Chemical induction, pathogenesis, and possible neoplastic fate in a teleost fi sh model. Toxicol Pathol19: 237— 250.
17.
Couch JA, Courtney LA (1987). N-Nitrosodiethylamine-induced hepatocarcinogenesis in estuarine sheepshead minnow (Cyprinodon variegatus): Neoplasms and related lesions compared with mammalian lesions. J Natl Cancer Inst79: 297—321.
18.
Craig JR, Peters RL, Edmondson HA (1989). Benign mesenchymal tumors and tumor-like conditions . In: Tumors of the Liver and Intrahepatic Bile Ducts. Hartmann WH, Sobin LH (eds). Armed Forces Institute of Pathology, Washington, DC, pp 63—101.
19.
David RM, Moore MR, Cifone MA, Finney DC, Guest D. (1999). Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesi s of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci50: 195—205.
20.
David RM, Moore MR, Finney DC, Guest D. (2000). Chronic toxicity of di(2-ethylhexyl)phthalate in rats. Toxicol Sci55: 433—443.
21.
Deschl U., Ernst H., Frantz JD, Goodman DG, Hartig F., Konishi Y., Küttler K., Popp JA, Pü schner H., Squire RA (1997). International Classifi cation of Rodent Tumours, Part I—The Rat. 10. Digestive System. Mohr U (ed). IARC Scientifi c Publication No 122, Lyon.
22.
Dixon D., Yoshitomi K., Boorman GA, Maronpot RR (1994). “Lipomatous” lesions of unknown cellular origin in the liver of B6C3F1 mice. Vet Pathol31: 173—182.
23.
Eder M. (1990). Pathologie des Wachstums und der Differenzierung . In: Allgemeine Pathologie und Pathologische Anatomie, 33rd ed, Eder M, Gedigk P (eds). Springer, Berlin, pp 227—297.
24.
Enzan H. (1985). Proliferation of Ito cells (fat-storing cells) in acute carbon tetrachloride liver injury. A light and electron microscopic autoradiographi c study. Acta Pathol Jpn35(6): 1301—1308.
25.
Eustis SL, Boorman GA, Harada T., Popp JA ( 1990). Liver. In: Pathology of the Fischer Rat , Boorman GA, Eustis SL, Elwell MR, Montgomery Jr CA, MacKenzie WF (eds). Academic Press, San Diego, pp 71—94.
Friedman SL (2000). Molecular regulation of hepatic fi brosis, an integrated cellular response to tissue injury. J Biol Chem275(4): 2247— 2250.
28.
Frith CH, Ward JM, Turusov VS (1994). Tumours of the liver. In: Pathology of Tumours in Laboratory Animals, Vol. 2, Tumours of the Mouse, Turusov VS, Mohr U (eds). International Agency for Research on Cancer, Lyon, France, pp 223—269.
29.
Goodman DG, Maronpot RR, Newberne PM, Pott JA, Squire RA (1994). Proliferative and selected other lesions in the liver of rats. In: Guides for Toxicologic Pathology. STP/ARP /AFIP, Washington, DC.
30.
Gopinath C., Prentice DE, Lewis DJ (1987). Atlas of Experimental Toxicological Pathology , Vol 13, MTP Press, Boston.
31.
Gourley IM, Popp JA, Park RD ( 1971). Myelolipomas of the liver in a domestic cat. J Am Vet Med Assoc158: 2053—2057.
32.
Greaves P. (1990). Histopathology of Preclinical Toxicity Studies . Elsevier, Amsterdam.
33.
Greaves P., Faccini JM (1984). Rat Histopathology. Elsevier , Amsterdam.
34.
Gressner AM (1994). Activation of proteoglycan synthesis in injured liver— A brief review of molecular and cellular aspects. EurJ Clin Chem Clin Biochem32: 225—237.
35.
Harada T., Enomoto A., Boorman GA, Maronpot RR (1999). Liver and gallbladder. In: Pathology of the Mouse, Maronpot RR (ed). Cache River Press, Vienna, IL, pp 140—162.
36.
Harada T., Maronpot RR, Enomoto A., Tamano S., Ward JM ( 1996). Changes in the liver and gallbladder. In: Pathology of the Aging Mouse, Vol 2, Mohr U, Dungworth DL , Capen CC, Carlton WW, Sundberg JP, Ward JM (eds). ILSI Press, Washington, DC, pp 207— 241.
37.
Haschek WM, Rousseaux CG (eds) (1998). Fundamentals of Toxicologic Pathology. Academic Press, San Diego.
38.
Hellerbrand C., Stefanovic B., Giordano F., Burchardt ER, Brenner DA (1999). The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo . J Hepatol30(1): 77—87.
39.
Ikeda K., Wakahara T., Wang YQ, Kadoya H., Kawada N., Kaneda K. (1999). In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology29(6): 1760—1767.
40.
Iredale JP, Benyon RC, Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., Arthur MJ (1998). Mechanisms of spontaneous resolution of rat liver fi brosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinas e inhibitors. J Clin Invest102(3): 538—549.
41.
Ishak KG, Rabin L. (1975). Benign tumors of the liver. Med Clin North Amer59:995—1013.
42.
Ito N., Moore MA, Bannasch P. (1984). Modifi cation of the development of N-nitrosomorpholine-induce d hepatic lesions by 2-acetyl amino fluorene, phenobarbital and 4,4'-diaminodiphenylmethane: A sequential histological and histochemical analysis. Carcinogenesis5: 335—342.
43.
Johnson SJ, Hines JE, Burt AD ( 1992a). Immunolocalization of proliferating perisinusoidal cells in rat liver. Histochem J24(2): 67—72.
44.
Johnson SJ, Hines JE, Burt AD ( 1992b). Phenotypic modulation of perisinusoidal cells following acute liver injury: A quantitative analysis. Int J Exp Pathol73(6): 765—772.
45.
Johnson SJ, Hines JE, Burt AD ( 1992c). Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol166(4): 351—358.
46.
Lombard LS, Fortna HM, Garner FM, Brynjolfsson G. (1968). Myelolipomas of the liver in captive wild Felidae . Vet Pathol5: 127—134.
47.
Maher JJ, Friedman SL, Roll FJ, Bissell DM (1988). Immunolocalization of laminin in normal rat liver and biosynthesi s of laminin by hepatic lipocytes in primary culture. Gastroenterology94(4): 1053—1062.
48.
Malley LA, Slone TW Jr, Makovec GT, Elliott GS, Kennedy GL Jr. (1995). Chronic toxicity/oncogenicity of dimethylacetamide in rats and mice following inhalation exposure. Fund Appl Toxicol28: 80—93.
49.
Maronpot RR , Haseman JK, Boorman GA, Eustis SE, Rao GN, Huff JE (1987). Liver lesions in B6C3F1 mice: The National Toxicology Program, experience and position. In: Mouse Liver Tumors, Chambers PL, Henschler D, Oesch F (eds). Arch Toxicol Suppl10, pp 10—26.
50.
Marra F., DeFranco R., Grappone C., Milani S., Pastacaldi S., Pinzani M., Romanelli RG, Laffi G., Gentilini P. (1998). Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infi ltration . Am J Pathol152(2): 423— 430.
51.
Marra F., DeFranco R., Grappone C., Parola M., Milani S., Leonarduzzi G., Pastacaldi S., Wenzel UO, Pinzani M., Dianzani MU, Laffi G., Gentilini P. (1999). Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med47(1): 66—75.
52.
Marra F., Gentilini A., Pinzani M., Choudhury GG, Parola M., Herbst H., Dianzani MU, Laffi G., Abboud HE, Gentilini P. (1997). Phosphatidylinosito l 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology112(4): 1297—1306.
53.
Marra F., Romanelli RG, Giannini C., Failli P., Pastacaldi S., Arrighi MC, Pinzani M., Laffi G., Montalto P., Gentilini P. (1999). Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology29(1): 140—148.
54.
Migaki G., Albert TF (1982). Lipoma of the liver in a bowhead whale. Vet Pathol19: 329—331.
55.
Niki T., Pekny M., Hellemans K., Bleser PD, Berg KV, Vaeyens F., Quartier E., Schuit F., Geerts A. (1999). Class VI intermediate fi lament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology29(2): 520—527.
56.
Nime F., Pickren JW, Vana J., Aronoff BL, Baker HW, Murphy GP (1979). The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer44: 1481—1489.
57.
Peters WM, Dixon MF, Williams NS (1983). Angiomyelolipoma of the liver. Histopathology7: 99—106.
58.
Pinzani M., Abboud HE, Gesualdo L., Abboud SL (1992). Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. Am J Physiol 262(4Pt1): C876—881.
59.
Pinzani M., Marra F., Carloni V. (1998). Signal transduction in hepatic stellate cells . Liver18(1): 2—13.
60.
Pinzani M., Milani S., De Franco R., Grappone C., Caligiuri A., Gentilini A., Tosti-Guerra C., Maggi M., Failli P., Ruocco C., Gentilini P. (1996). Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology110(2): 534— 548.
61.
Ramadori G. , Veit T., Schwogler S., Dienes HP, Knittel T., Rieder H., Meyer zum Buschenfelde KH ( 1990). Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol59(6): 349—357.
62.
Ramchand S. , Ahmed Y., Baskerville L. (1970). Lipoma of the liver. Arch Pathol90: 331—333.
63.
Riede UN, Mohr W. ( 1995). Tendofasziale Gewebe. In: Allgemeine und Spezielle Pathologie, 4th ed, Riede UN, Schaefer HE (eds). Georg Thieme, Stuttgart , pp 1155—1158.
64.
Ritchie AC (1990). Textbook of Pathology, 9th ed, Lea and Febiger, Philadelphia , pp 1940—1941.
65.
Rockey DC, Boyles JK, Gabbiani G., Friedman SL (1992). Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol24(2): 193—203.
66.
Rockey DC, Fouassier L., Chung JJ, Carayon A., Vallee P., Rey C., Housset C. (1998). Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells. Hepatology27(2): 472—480.
67.
Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G., Friedman SL (1992). Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology16(3): 776—784.
68.
Schmitt-Graff A., Kruger S., Bochard F., Gabbiani G., Denk H. (1991). Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol138(5): 1233— 1242.
69.
Stroebel P. , Mayer F., Zerban H., Bannasch P. (1995). Spongiotic pericytoma: A benign neoplasm deriving from the perisinusoidal (Ito) cells in rat liver . Am J Path146: 903—913.
70.
Takase S., Leo MA, Nouchi T., Lieber CS (1988). Desmin distinguishes cultured fat-storing cells from myofi broblasts, smooth muscle cells and fi broblasts in the rat. J Hepatol6(3): 267—276.
71.
Tennant RW, Elwell MR, Spalding JW, Griesemer RA (1991). Evidence that toxic injury is not always associated with induction of chemical carcinogenesis. Mol Carcinog4(6): 420—440.
72.
Theret N., Lehti K., Musso O., Clement B. (1999). MMP2 activation by collagen I and concanavali n A in cultured human hepatic stellate cells. Hepatology30(2): 462—468.
73.
Thompson KC, Trowern A., Fowell A., Marathe M., Haycock C., Arthur MJ, Sheron N. (1998). Primary rat and mouse hepatic stellate cells express the macrophag e inhibitor cytokine interleukin-10 during the course of activation in vitro. Hepatology28(6): 1518—1524.
74.
Tillmann T., Kamino K., Dasenbrock C., Germann PG, Kohler M., Morawietz G., Campo E., Cardesa A., Tomatis L., Mohr U. ( 1999). Ito cell tumor: Immunohistochemica l investigation s of a rare lesion in the liver of mice. Toxicol Pathol27: 364—369.
75.
Van Eyken P., Geerts A., De Bleser P., Lazou JM, Vrijsen R., Sciot R., Wisse E., Desmet VJ (1992). Localization and cellular source of the extracellular matrix protein tenascin in normal and fi brotic rat liver. Hepatology15(5): 909—916.
76.
Wahle BS, Sangha GK, Lake SG, Sheets LP, Croutch C., Christenson WR (1999). Chronic toxicity and carcinogenicity testing in the Sprague—Dawley rat of a prospective insect repellant (KBR 3023) using the dermal route of exposure. Toxicology142: 41—56.
77.
Wang SC, Ohata M., SchrumL., Rippe RA, Tsukamoto H. (1998). Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem273(1): 302—308.
78.
Wang XD (1999). Chronic alcohol intake interferes with retinoid metabolism and signaling. Nutr Rev57(2): 51—59.
79.
Zerban H., Bannasch P. (1983). Spongiosis hepatis in rats treated with low doses of hepatotropic nitrosamines. Cancer Lett19: 247—252.
